Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy ...

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the ...

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

A group of attorneys general from 27 states and the District of Columbia is suing 23andMe (OTC:MEHCQ) to prevent the bankrupt ...

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

The states argue that customers should have control over their personal information, which cannot be treated like ordinary ...